|
| Science Forum Index » Medicine - Cancer Forum » Angiogenesis inhibitors in breast cancer therapy... |
|
Page 1 of 1 |
|
| Author |
Message |
| scimedweb... |
 Posted: Fri Jul 03, 2009 12:03 am |
|
|
|
Guest
|
Angiogenesis inhibitors in breast cancer therapy
A detailed description of angiogenesis inhibitors (bevacizumab,
sunitinib, vandetanib, pazopanib, ramucirumab, ABT-869, AV-951,
PTC299, AMG 386, aflibercept) that are currently used in routine
therapy or are in clinical trials in breast cancer patients.
In the book « Molecular Therapy of Breast Cancer: Classicism Meets
Modernity ».
by Marc Lacroix
InTextoResearch, Baelen (Liège, Wallonia), Belgium
Nova Sciences Publishers, New York, ISBN 978-1-60741-593-0
https://www.novapublishers.com/catalog/product_info.php?cPath=23_29&products_id=10042&osCsid=8fed1efc6158a0ba4004bec047b66ff0 |
|
|
| Back to top |
|
|
|
|
|
All times are GMT - 5 Hours
The time now is Sat Nov 28, 2009 8:42 am
|
|
